OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
| Revenue (Most Recent Fiscal Year) | $185.83M |
| Net Income (Most Recent Fiscal Year) | $-19.50M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.31 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.56 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 73.15 |
| Pre-Tax Margin (Trailing 12 Months) | -17.55% |
| Net Margin (Trailing 12 Months) | -19.77% |
| Return on Equity (Trailing 12 Months) | -5.86% |
| Return on Assets (Trailing 12 Months) | -5.20% |
| Current Ratio (Most Recent Fiscal Quarter) | 12.34 |
| Quick Ratio (Most Recent Fiscal Quarter) | 10.94 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.56 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.30 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.21 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.11 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.42 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 74.80M |
| Free Float | 71.88M |
| Market Capitalization | $212.43M |
| Average Volume (Last 20 Days) | 0.69M |
| Beta (Past 60 Months) | 0.42 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 93.50% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |